Adjuvant Gemcitabine, BCG for NMIBC Offer Similar Efficacy

Adjuvant Gemcitabine, BCG for NMIBC Offer Similar Efficacy

Intravesical gemcitabine may have similar efficacy and a lower incidence of dysuria and hematuria compared with bacillus Calmette-Guérin (BCG) for the adjuvant treatment of...

   Accelerating Efforts to Eliminate Cervical Cancer Around the World

Accelerating Efforts to Eliminate Cervical Cancer Around the World

This blog post was written by Chris Hansen, president of the American Cancer Society Cancer Action Network (ACS CAN). ACS CAN is the nonprofit, nonpartisan advocacy affiliate of...

7 exercise myths debunked

7 exercise myths debunked

7 Exercise myths debunked March 2014 : 7 exercise myths debunked 7 exercise myths debunked Staying physically active is an important step in reducing your risk for cancer. Get...

Surgery-First Strategy Cost-Effective in Benign Prostatic Hyperplasia

Surgery-First Strategy Cost-Effective in Benign Prostatic Hyperplasia

NEW YORK (Reuters Health) - Using surgery as an initial treatment for moderate-to-severe benign prostatic hyperplasia (BPH) is more economically attractive than upfront...

E-Cigarette Smoke Possibly Carcinogenic to Lung, Bladder

E-Cigarette Smoke Possibly Carcinogenic to Lung, Bladder

(HealthDay News) -- Electronic cigarette (e-cigarette) smoke causes damage to DNA and reduces repair activity in a mouse model and in human cells, according to a study published...

Bladder Cancer Risk Not Lowered With Androgen Deprivation

Bladder Cancer Risk Not Lowered With Androgen Deprivation

Previous research documented the presence of androgen receptors in the bladder wall, prompting speculation that androgens may explain, at least in part, why bladder cancer is...

Single PSA Screening Has No Effect on Prostate Cancer Mortality

Single PSA Screening Has No Effect on Prostate Cancer Mortality

Single PSA screening tests make no significant difference in prostate cancer mortality, according to a new study. As part of the Cluster Randomized Trial of PSA Testing for...

Prostate Cancer Radiotherapy Effective Long-Term

Prostate Cancer Radiotherapy Effective Long-Term

Definitive radiotherapy for prostate cancer (PCa), even high-risk cases, is effective long-term, Australian researchers concluded. After a median follow-up of 92 months...

Higher Radiation Dose Key to Better Brachytherapy Outcomes

Higher Radiation Dose Key to Better Brachytherapy Outcomes

SAN DIEGO—Higher radiation doses are critical to optimizing long-term outcomes following brachytherapy for prostate cancer (PCa), a study presented at the American Urological...

More Radiation May Not Improve Survival in Localized Prostate Cancer

More Radiation May Not Improve Survival in Localized Prostate Cancer

Escalating the dose of radiation may not lead to increased survival for patients with localized and locally advanced prostate cancer (PCa), a new study finds. “In the field...

Treatment-Related Hospitalizations Similar for PCa Surgery, Radiation

Treatment-Related Hospitalizations Similar for PCa Surgery, Radiation

The odds of hospital readmission for complications do not differ significantly between radical surgery and radiation therapy for relatively healthy, older men with localized...

PCa Patients Treated at High-Volume Radiation Centers Fare Better

PCa Patients Treated at High-Volume Radiation Centers Fare Better

Prostate cancer (PCa) patients experience better survival when they are treated at high-volume radiation centers, a new study finds. “The primary implication of our study is...